Bristol-Myers Squibb Company
Biaryl kinase inhibitors
Last updated:
Abstract:
The present disclosure is directed to biaryl compounds of formula (I) which can inhibit AAK1 (adaptor associated kinase 1), compositions comprising such compounds and their use for treating e.g. pain, Alzheimer's disease, Parkinson's disease and schizophrenia. ##STR00001##
Status:
Grant
Type:
Utility
Filling date:
29 Sep 2016
Issue date:
28 Jan 2020